Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation

Bibliography

• de Almeida AB, Freedman DO. Epidemiology and immunopathology of bancroftian filariasis. Microbes Infect 1999;1:1015-22
   PubMed Web of Science ®Google Scholar
• Haque AK. The pathology and pathophysiology of mycobacterial infections. J Thorac Imaging 1990;5:8-16
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8
   PubMed Web of Science ®Google Scholar
• Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951-60
   PubMed Web of Science ®Google Scholar
• Uhley HN, Leeds SE, Sampson JJ, Friedman M. Role of pulmonary lymphatics in chronic pulmonary edema. Circ Res 1962;11:966-70
   PubMed Web of Science ®Google Scholar
• Wilting J, Becker J, Buttler K, Weich HA. Lymphatics and inflammation. Curr Med Chem 2009;16:4581-92
   PubMed Web of Science ®Google Scholar
• Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev 2001;50:3-20
   PubMed Web of Science ®Google Scholar
• Senior J, Gregoriadis G. Is half-life of circulating small unilamellar liposomes determined by changes in their permeability? FEBS Lett 1982;145:109-14
   PubMed Web of Science ®Google Scholar
• Michael E, Bundy DA. Global mapping of lymphatic filariasis. Parasitol Today 1997;13:472-6
   PubMedGoogle Scholar
• Chandy A, Thakur AS, Singh MP, Manigauha A. A review of neglected tropical diseases: filariasis. Asian Pac J Trop Med 2011;4:581-6
   Web of Science ®Google Scholar
• Muranishi S, Fujita T, Murakami M, Yamamoto A. Potential for lymphatic targeting of peptides. J Control Release 1997;46:157-64
   Web of Science ®Google Scholar
• Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001;50:61-80
   PubMed Web of Science ®Google Scholar
• Oussoren C, Zuidema J, Crommelin DJ, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1997;1328:261-72
   PubMed Web of Science ®Google Scholar
• Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 2011;42:11-18
   PubMed Web of Science ®Google Scholar
• Shin SB, Cho HY, Kim DD, et al. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery. Eur J Pharm Biopharm 2010;74:164-71
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Kota J, McLeod VM, et al. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. J Control Release 2009;140:108-16
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJ, Edwards GA, et al. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003;20:91-7
   PubMed Web of Science ®Google Scholar
• Rubas W, Grass GM. Gastrointestinal lymphatic absorption of peptides and proteins. Adv Drug Deliv Rev 1991;7:15-69
   Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 2009;5:184-91
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu J, Li S, et al. Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: influence of Poloxamer 188 coating on phagocytic uptake. J Microencapsul 2008;25:203-9
   PubMed Web of Science ®Google Scholar
• Ricci M, Puglia C, Bonina F, et al. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci 2005;94:1149-59
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze -drying of nanoparticles : formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688-713
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, et al. Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces 2012;97:109-16
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Reimold I, et al. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm 2012;439:49-62
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces 2011;88:483-9
   PubMed Web of Science ®Google Scholar
• Boyd M, Risovic V, Jull P, et al. A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: cannulation of the mesenteric and thoracic lymph ducts within the rat. J Pharmacol Toxicol Methods 2004;49:115-20
   PubMedGoogle Scholar
• Bolla S, Boinpally RR, Poondru S, et al. Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects. J Clin Pharmacol 2002;42:327-31
   PubMed Web of Science ®Google Scholar
• Mathew N, Kalyanasundaram M. A high performance liquid chromatographic method for the estimation of diethylcarbamazine content in medicated salt samples. Acta Trop 2001;80:97-102
   PubMed Web of Science ®Google Scholar
• Ahlin P, Kristl J, Smid-Korbar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharm 1998;48:259-67
   Google Scholar
• Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions. Int J Pharm 1998;168:221-9
   Web of Science ®Google Scholar
• Bargoni A, Cavalli R, Zara GP, et al. Trans-mucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration of rats Part II-tissue distribution. Pharmacol Res 2001;43:497-502
   PubMed Web of Science ®Google Scholar
• Bunjes H, Unruh T. Characterisation of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev 2007;59:379-402
   PubMed Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, et al. The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces 2011;84:117-30
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan MA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm 2010;76:127-37
   PubMed Web of Science ®Google Scholar
• Hawley AE, Davis SS, Illum L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 1995;17:129-48
   Web of Science ®Google Scholar
• Illum L, Church AE, Butterworth MD, et al. Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration. Pharm Res 2001;18:640-5
   PubMed Web of Science ®Google Scholar
• Stolnik S, Daudali B, Arien A, et al. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochim Biophys Acta 2001;1514:261-79
   PubMed Web of Science ®Google Scholar
• Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and non-ionic emulsifier. Eur J Pharm Biopharm 2005;61:77-86
   PubMed Web of Science ®Google Scholar
• Babchin AJ, Schramm LL. Osmotic repulsion force due to adsorbed surfactants. Colloids Surf B Biointerfaces 2012;91:137-43
   PubMed Web of Science ®Google Scholar
• Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm 1998;46:255-63
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012;14:1-16
   PubMed Web of Science ®Google Scholar
• zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149-55
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996;129:159-73
   Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Paliwal R, Paliwal SR, Mishra N, et al. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm 2009;380:181-8
   PubMed Web of Science ®Google Scholar
• Videira MA, Botelho MF, Santos AC, et al. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002;10:607-13
   PubMed Web of Science ®Google Scholar
• Lu B, Xiong SB, Yang H, et al. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 2006;28:86-95
   PubMed Web of Science ®Google Scholar